SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology & Drugs
An SI Board Since February 2001
Posts SubjectMarks Bans
232 7 0
Emcee:  2MAR$ Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
107Shares of drugmaker NOVN ($20-$14.90) skid on Wyeth hormone-study news stockchar2MAR$-7/9/2002
106LGND Ligand Pharms sees Q2 revs lower; warns for full year (9.54 - $7.00) Com2MAR$-7/9/2002
105EDIT: Biotech Dates , meant MLNM -->7/16 (tues) in the A/H... Then GENZ 7/17 2MAR$-7/9/2002
104Biotech dates I could find : ABGX=8/23...ests= -41c ADRX=8/26...ests=9c AFFX=8/2MAR$-7/9/2002
103<font color=fuchsia> ****START Q2 2002 EARNINGS ****SusieQ1065-7/8/2002
102Time to Let the Air Out If you think biotech stocks are headed for a breakout aSusieQ1065-7/8/2002
101CEPH Quarterly Conference Call Invitation Aug 5th...(mark calendar) 2MAR$-7/8/2002
100'member playing ADRX long twice last week , and it was sure trading really &2MAR$-7/5/2002
9908:49 ET ADRX Andrx cut to Mkt Outperform at Goldman (21.69) Goldman Sachs SusieQ1065-7/3/2002
9807:44 ET DNA Genentech downgraded by Deutsche Securities (29.95) Deutsche SSusieQ1065-7/3/2002
97Alkermes leads drug stocks lower FTC, FDA decisions weigh on biotech and pharma2MAR$-7/1/2002
96Double disappointment for IDEC Pharmaceuticals($36.25) (adds byline, quotes2MAR$-6/10/2002
95a must~read, Marshie... 13:59 ET 6/6/02 Biotech Sector : The last thing the biSusieQ1065-6/7/2002
94-Merck cautions about use of Zocor with heart drug (Adds details, closing s2MAR$-6/6/2002
93Biogen to Provide Mid-Quarter Financial Update Conference Call -- Fr2MAR$-6/6/2002
92Anti-Cancer Drug Discovery & Development Summit 2002 to Take Place June 17-12MAR$-5/29/2002
91MLNM Study Shows Massachusetts Firm's Cancer-Fighting Drug Halts Progression2MAR$-5/21/2002
90Biotechnology Seeks End to Slump (NY Times 5/19) By ANDREW POLLACK nytimes.com 2MAR$-5/19/2002
89Protein Design Won't Seek Zamyl Approval May 19 1:45pm ET ORLANDO, FlSusieQ1065-5/19/2002
88Glad your well and happy...was I the only one shorting AMAT on earns A/H ? Bet 2MAR$-5/16/2002
87hi...the BBH has "R" at 101, which is big swing low it broke down fromSusieQ1065-5/16/2002
86Medicare to cover Avonex MS drug-WSJ NEW YORK, May 16 (Reuters) - Medicare,2MAR$-5/16/2002
85Hi "shortie" ;-) watching BGEN here too which is not too happy and fa2MAR$-5/16/2002
8405/16/02 ImClone Systems reports wider Q1 losses (IMCL) By Tomi Kilgore ImCloSusieQ1065-5/16/2002
8307:01 ET IMCL Imclone: Merck KGaA not participating in Erbitux filing -- DJ (SusieQ1065-5/16/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News